Sentences with phrase «increased its dividend each year for»

I read that Apple's CEO has said he is not a fan of one - time payments, but they have increased their dividend every year for the last few years, so I am expecting another increase this year.
It contains companies in the S&P 500 Index that have increased dividends every year for the last 25 straight years.
To be a Dividend Aristocrat, a company must have increased its dividend each year for 25 consecutive years.
For example, your full - service broker might offer you a list of potential investments based upon your preferred investing strategy (e.g., if you like stable companies that have increased their dividends every year for 25 years, they can have a report prepared for you that lists the ticker symbols, names, and dividend yield of each publicly traded company in the United States that fits your criteria).
Given that United Technologies has made a conscious effort to increase the dividend each year for 23 years straight, I expect them to continue to do so.
The S&P High Yield Dividend Aristocrats ® is designed to track a basket of stocks from the S&P Composite 1500 ® that have consistently increased their dividends every year for at least 20 years.
25 + Year Dividend Increase Stocks: Companies that have increased their dividends every year for at least 25 years (from Dividend.com).
The S&P 500 Dividend Aristocrats Index selects companies in the S&P 500 that have increased their dividends every year for at least 25 consecutive years.
Dividend Aristocrats are stocks that have increased their dividends every year for at least 25 consecutive years.
In Class of 2009, S&P selected 52 stocks from the index which have increased their dividends every year for at least 25 consecutive years.
Given that Norfolk Southern has made a conscious effort to increase the dividend each year for 15 years straight, I expect them to continue to do so.
I read that Apple's CEO has said he is not a fan of one - time payments, but they have increased their dividend every year for the last few years, so I am expecting another increase this year.
Dividend Aristocrats are those stocks that have established track records of increasing dividends every year for at least 25 years.
Proctor & Gamble (PG) is a multinational consumer goods company, which has paid an increasing dividend every year for the last 61 years.
Our list is comprised exclusively from David Fish's current list of 102 Dividend Champions, companies that have increased their dividends every year for at least 25 years.
He recommended ProShares S&P 500 Dividend Aristocrats ETF (NOBL), which tracks S&P 500 companies that have increased their dividends every year for 25 consecutive years.
Hyman said that while we're currently in an earnings recession, the 50 companies in the S&P 500 Dividend Aristocrats Index — companies that have increased their dividend every year for at least 25 years — are generating 2 % positive earnings growth.
S&P 500 Dividend Aristocrats measures the performance of S&P 500 companies that have increased dividends every year for the last 25 consecutive years.
That means that the risk profile can look attractive too: a dividend yield of 2.8 % is available even when restricting attention only to those members of the Europe 350 that have increased dividends every year for the past 10 years *.
This final article in the series will cover Dividend Challengers, companies that increased their dividend every year for a minimum of five, to up to nine consecutive years.
Our first article covered Dividend Champions, dividend paying stocks with a history of increasing the dividend every year for at least 25 years and can be found here.
Our first article covered Dividend Champions, dividend paying stocks with a history of increasing the dividend every year for at least 25 years and can Read more about The Top 25 Best Dividend Challengers To Buy Today -LSB-...]
A Dividend Challenger is defined as a company that has increased its dividend every year for 5 - 9 straight years.
Nevertheless, the one common denominator with all these research candidates is that they have all increased their dividends each year for the past decade or more.
S&P 500 ® Dividend Aristocrats ® measure the performance of S&P 500 companies that have increased dividends every year for the last 25...
S&P / TSX Canadian Dividend Aristocrats ® measure the performance companies included in the S&P Canada BMI that have followed a policy of consistently increasing dividends every year for at least five years.
You won't have to go far for investment ideas, for David Fish's Dividend Champions, Contenders, and Challengers list has compiled invaluable data on more than 800 US - listed stocks that have increased their dividends each year for at least the last five consecutive years.
Those companies have increased their dividends every year for 52, 27, and 58 years, respectively.
Companies such as McDonald's (MCD), Coca - Cola (KO), and Johnson & Johnson (JNJ) have increased their dividends every year for decades.
The S&P 500 Dividend Aristocrats index measures the performance of large cap, blue chip companies within the S&P 500 that have followed a policy of increasing dividends every year for at least 25 consecutive years.
These stocks have increased dividends every year for the past 25 years.
One easy way to find these stocks is to look at Standard & Poor's list of «Dividend Aristocrats,» which are stocks that have increased their dividends every year for at least 25 years.
Family Dollar has increased its dividend every year for the past 25 years and just last week raised the dividend by a whopping 24 %.
The Dividend Aristocrats Index is comprised only of businesses in the S&P 500 that have paid increasing dividends every year for 25 or more consecutive years.
The most well - known is the S&P 500 Dividend Aristocrats, composed of the largest U.S. firms that have increased their dividend every year for at least 25 years.
According to David Fish's list, Clorox has paid and increased its dividend every year for 37 consecutive years.

Not exact matches

With this Armonk, N.Y. — based technology giant, you're getting a company that's increased its dividend for 18 straight years and has a proven that it can grow its earnings over the long term.
If these increases occur, this will be the sixth consecutive year in which Telus has increased its divided by 10 per cent or more in what Entwistle calls a multi-year dividend growth program, which remains a priority for the company.
One way small investors can imitate that approach: Buying the ProShares S&P 500 Dividend Aristocrats ETF (NOBL), which owns shares in companies that have increased dividends for at least 25 consecutive years.
«We believe the bogey for investors is a 15 percent increase to Apple's total reported capital return number (shares repurchase plus past dividends), which would imply a $ 150 billion headline number, up from $ 130 billion announced last year,» said Gene Munster, an analyst at Piper Jaffray, in a recent note.
Stanley Black & Decker has increased its dividend for the past 50 years in a row, and now yields 1.5 %.
For example, Columbia Management expects double - digit dividend increases for S&P 500 stocks this yeFor example, Columbia Management expects double - digit dividend increases for S&P 500 stocks this yefor S&P 500 stocks this year.
Coca - Cola has increased its dividend for 49 consecutive years, PepsiCo for the past 40.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
-LSB-...] NextEra Energy has successfully increased its dividend for 22 years, making it part of the elite Dividend Achievedividend for 22 years, making it part of the elite Dividend AchieveDividend Achievers list.
-LSB-...] American Water Works has successfully increased its dividend payments for the pat 8 years.
-LSB-...] The Dividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivDividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivdividend payments for at least ten consecutive years.
Following what will be one of its most profitable years ever in North America, General Motors raised its earnings guidance for 2016, while also dramatically increasing its stock buyback program and its quarterly dividend.
Reuben Gregg Brewer (Hormel Foods): Protein - focused food manufacturer Hormel has increased its dividend every single year for an amazing 52 consecutive years.
The Dividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivDividend Achievers Index refers to all public companies that have successfully increased their dividend payments for at least ten consecutivdividend payments for at least ten consecutive years.
a b c d e f g h i j k l m n o p q r s t u v w x y z